# Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis

> **NCT06750588** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Nterica Bio inc** · enrollment: 12 (estimated)

## Conditions studied

- Alcohol-Associated Hepatitis

## Interventions

- **DRUG:** bacteriophage preparation
- **DRUG:** Bacteriophage preparation
- **DRUG:** bacteriophage preparation
- **DRUG:** bacteriophage preparation

## Key facts

- **NCT ID:** NCT06750588
- **Lead sponsor:** Nterica Bio inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-05
- **Primary completion:** 2026-04
- **Final completion:** 2026-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06750588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06750588, "Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06750588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*